BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
CYP51
,
G-protein-coupled receptor binding
,
Leukemia
,
Hippocampus
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
VH3
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
No diseases found
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
No compounds found
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
No perturbed genes found
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Spontaneous regression of CTL: clinical and biological features of 9 cases
Explore Curated Studies Results
Literature
Most Relevant Literature
Peptidoglycan-linked protein A promotes T cell-dependent antibody expansion during Staphylococcus au…
Differential binding of heavy chain variable domain 3 antigen binding fragments to protein A chromat…
Recombination, transcription, and diversity of a partially germline-joined VH in a mammal.
Minimal residual disease detection in Tunisian B-acute lymphoblastic leukemia based on immunoglobuli…
Different pattern of immunoglobulin gene usage by HIV-1 compared to non-HIV-1 antibodies derived fro…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chron…
Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leuk…
Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lym…
Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small…
Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptim…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ